Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
Eisai Inc.
University of California, Irvine
Qurient Co., Ltd.
Duke University
Essen Biotech
Essen Biotech
New Phase Ltd.
DualityBio Inc.
Grey Wolf Therapeutics
Second Life Therapeutics
RenJi Hospital
University Health Network, Toronto
Shanghai Junshi Bioscience Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
EtiraRx Australia Pty Ltd
Anhui Provincial Hospital
Washington University School of Medicine
Novita Pharmaceuticals, Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
University Hospital, Antwerp
Universidade Federal de Pernambuco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Comprehensive Support Project for Oncology Research
Pfizer
Celldex Therapeutics
Zhejiang University
Fusion Pharmaceuticals Inc.
Children's Oncology Group
Massachusetts General Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Klus Pharma Inc.
City of Hope Medical Center
Celldex Therapeutics
Shanghai Yunying Medical Technology
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Hospices Civils de Lyon
MultiVir, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Zhujiang Hospital
Chinese PLA General Hospital